Glaucoma study: AI-based glaucoma screening vs IOP measurement
Official title The Glaucoma and Retinopathy Screening Study
ClinicalTrials.gov ID: NCT06882356
What this study is testing
- What it's testing
- The study wants to see if an AI algorithm that looks at eye photos, measures eye pressure, and tests side vision can detect glaucoma.
- Who it's for
- People who are having a diabetic eye screening and may be at risk for glaucoma.
- What's involved
- Participants will have a photo of the back of their eye taken, their eye pressure measured, and, if needed, a side‑vision test using a headset.
- Time commitment
- The study involves a single visit for the eye photo, pressure check, and possible vision test.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Individuals with diabetes undergoing AI-based screening for diabetic retinopathy using the LumineticsCore (Digital Diagnostics) system at primary...
- Individuals who are able and willing to provide informed consent for participation in the study.
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
- Chelsea, Massachusetts, United States
- Lynn, Massachusetts, United States
- Saugus, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States; Chelsea, Massachusetts, United States; Lynn, Massachusetts, United States; Saugus, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.